What does this research mean for the field?

A structured clinical workflow can be implemented to reduce the risk of lead-related superior vena cava (SVC) syndrome, which accounts for approximately 30% of all SVC syndrome cases. Novelty: ClaimNovelty.METHODOLOGICAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

March 3, 2026Open Access

Proposed workflow for the prevention of lead-related superior vena cava syndrome

Key Points

Lead-related superior vena cava syndrome results from stenosis of the SVC, leading to significant symptoms.
In approximately 30% of patients, SVC syndrome is linked to cardiac implantable electronic devices.

Structured PICO

Population

Patients at risk of lead-related superior vena cava (SVC) syndrome

Intervention

Structured clinical workflow

A proposed clinical workflow aims to mitigate the risk of lead-related superior vena cava syndrome, a complication responsible for roughly 30% of all SVC syndrome cases.

Abstract

In this viewpoint, after an overview of the background of lead-related superior vena cava (SVC) syndrome, we propose a structured clinical workflow intended to reduce the risk of lead-related SVC syndrome. Superior vena cava (SVC) syndrome is a rare condition of stenosis of the SVC resulting in symptoms. In the majority of 60% of the patients, SVC syndrome is caused by a malignancy. However, in approximately 30% of all the patients with SVC syndrome, it is related to cardiac implantable electronic device (CIED) leads and central venous catheters (CVC).

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Daniëls et al. (Thu,) studied this question.

synapsesocial.com/papers/69a75f4cc6e9836116a2a930 https://doi.org/https://doi.org/10.1016/j.hroo.2026.01.025

Bookmark

View Full Paper